Showing results (681-690 of 903) with videos related to

Sort By:
Pageof 91
The Lancet. Psychiatry|March 28, 2020
Blood tests to diagnose schizophrenia: self-imposed limits in psychiatryCarsten Korth, Heiner Fangerau
The Lancet. Psychiatry|March 23, 2020
Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trialJulia Bondar, Arthur Caye, Adam M Chekroud, et al.
The Lancet. Psychiatry|October 18, 2020
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trialErik Johnsen, Rune A Kroken, Else-Marie Løberg, et al.
The Lancet. Psychiatry|October 18, 2020
Brain-based mediation of non-conscious reduction of phobic avoidance in young women during functional MRI: a randomised controlled experimentPaul Siegel, Zhishun Wang, Lilly Murray, et al.
The Lancet. Psychiatry|October 18, 2020
Thinking about suicidal thinkingAllan House, Nav Kapur, Duleeka Knipe
The Lancet. Psychiatry|May 7, 2022
Designing clinically useful psychopharmacological trials: challenges and ways forwardAstrid Chevance, Philippe Ravaud, Victoria Cornelius, et al.
The Lancet. Psychiatry|December 14, 2020
Trajectories of anxiety and depressive symptoms during enforced isolation due to COVID-19 in England: a longitudinal observational studyDaisy Fancourt, Andrew Steptoe, Feifei Bu
The Lancet. Psychiatry|June 6, 2017
Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort studyJari Tiihonen, Antti Tanskanen, Fabian Hoti, et al.
The Lancet. Psychiatry|February 10, 2022
Structural brain measures among children with and without ADHD in the Adolescent Brain and Cognitive Development Study cohort: a cross-sectional US population-based studyJoel Bernanke, Alex Luna, Le Chang, et al.
The Lancet. Psychiatry|February 13, 2022
Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trialSuma Jacob, Jeremy Veenstra-VanderWeele, Declan Murphy, et al.
Pageof 91